|
|
Can Science be a Business? Lessons from Biotech (Harvard Business Review) by Gary Pisano |
|
Can Science be a Business? Lessons from Biotech (Harvard Business Review)
Publisher: Harvard Business School Publishing
Author: Gary Pisano
Audio lenght: 49 min.
In 1976, Genentech, the first biotechnology company, was founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche of new drugs has hit the market, and the long-awaited breakthrough in R&D productivity has yet to materialize. This disappointing performance raises a question: Can organizations motivated by the need to make profits and please shareholders successfully conduct basic scientific research as a core activity? From the October 2006 issue of Harvard Business Review.
More details on Can Science be a Business? Lessons from Biotech (Harvard Business Review)
Limited Time Offer - Get Your First 3 Months at Audible for $7.49/month!
 |
| |
|
